BARD SOFT MESH, MODELS 0117001, 0117002, 0117003, 0117004, 0117005, 0117006, 0117007

K033814 · C.R. Bard, Inc. · FTL · Mar 1, 2004 · General, Plastic Surgery

Device Facts

Record IDK033814
Device NameBARD SOFT MESH, MODELS 0117001, 0117002, 0117003, 0117004, 0117005, 0117006, 0117007
ApplicantC.R. Bard, Inc.
Product CodeFTL · General, Plastic Surgery
Decision DateMar 1, 2004
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.3300
Device ClassClass 2
AttributesTherapeutic

Intended Use

The proposed device is indicated to reinforce soft tissue where weakness exists, i.e., repair of hernias and chest wall defects.

Device Story

Bard Soft Mesh is a sterile, single-use surgical mesh for reinforcing soft tissue during hernia and chest wall defect repairs. Constructed from polypropylene monofilament (approx. 0.004 inch diameter), the mesh features a specific knit pattern providing bi-directional flexibility, a thin profile, and reduced material volume compared to traditional polypropylene meshes. Available in various rectangular sheets and pre-shaped forms, it is intended for use by surgeons in clinical settings. The device provides mechanical support to weakened tissue, facilitating repair. Unused mesh may be resterilized per instructions.

Clinical Evidence

Bench testing only. Biocompatibility testing confirmed the material is non-toxic and non-sensitizing. Laboratory testing verified that the design and material meet established specifications for consistent performance.

Technological Characteristics

Polypropylene monofilament surgical mesh; 0.004-inch filament diameter; knitted construction for bi-directional flexibility; sterile, single-use; available in rectangular sheets and pre-shaped forms.

Indications for Use

Indicated for reinforcement of soft tissue where weakness exists, specifically for the repair of hernias and chest wall defects in patients requiring surgical intervention.

Regulatory Classification

Identification

Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ### SECTION VII. # 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS FOR BARD SOFT MESH ### A. Submitter Information | Submitter's Name: | Davol, Inc. | |----------------------|--------------------------------| | Address: | Subsidiary of C. R. Bard, Inc. | | | 100 Sockanossett Crossroad | | | Cranston, RI 02920 | | Telephone: | 401-463-7000 ext. 2263 | | Fax: | 401-463-3845 | | Contact Person: | Suzanne LaScalza | | Date of Preparation: | December 5, 2003 | #### Device Name B. | Trade name: | Bard Soft Mesh | |----------------------|--------------------------| | Common/Usual name: | Surgical Mesh | | Classification name: | Surgical Mesh, Polymeric | #### Predicate Device Names C. | Trade name: | Bard Mesh (Davol Inc.) | |-------------|--------------------------------------------------------| | Trade name: | Atrium ProLite Ultra Mesh (Atrium Medical Corporation) | | Trade name: | Ethicon Mersilene Polyester Fiber Mesh (Ethicon, Inc.) | ### D. Device Description The proposed Bard Soft Mesh is a single layer of mesh constructed from polypropylene monofilament with a diameter of approximately 0.004 inches. The mesh is knitted to form a strong, porous, support material. The small diameter of the polypropylene monofilament allows for a thin profile and creates a mesh with increased flexibility and a reduced amount of material compared to traditional monofilament polypropylenc meshes. The proposed device is manufactured utilizing a strong knit design that allows for bi-directional flexibility and tailoring in any direction. The proposed device will be marketed as a stcrile, single use device and will be available in several sizes of rectangular sheets and pre-shaped forms. The option to restcrilize unused mesh has been provided in the instructions for use. CONFIDENTIAL {1}------------------------------------------------ K033814 page 2 of 2 #### Intended Use E. The proposed device is indicated to reinforce soft tissue where weakness exists, i.e., repair of hemias and chest wall defects. ### Summary of Similarities and Differences in Technological F. Characteristics, Performance and Intended Use Bard Soft Mesh and the predicate Bard Mesh have an identical intended use. Both devices are indicated to reinforce soft tissue where weakness exists, i.c., repair of hernias and chest wall defects. The proposed device has similar physical attributes and performance characteristics as the predicates Bard Mesh, ProLite Ultra and Mersilene Mesh. Furthermore, it has the same materials and similar manufacturing methods as the predicate Bard Mesh. The key differences in the proposed device compared to the predicate devices is in the diameter of the polypropylene monofilaments and the knit pattern of the mesh. In order to create a thinner, lighter weight mesh while also reducing the amount of material used in the mesh compared to traditional monofilament polypropylene meshes, the proposed device was constructed from monofilaments with a diameter of approximately 0.004 inches similar to the prodicate ProLite Ultra. The knit pattern of the mesh was designed in order to create a mesh with a soft feel and to allow for a more even stretch in both directions of the prosthesis. #### Performance Data ੁੱ Biocompatibility and bench testing have been completed and support the safety and effectiveness of Bard Soft Mesh for its intended use. The biocompatibility test results show that the material used in the design and manufacture of the device is non-toxic and non-sensitizing to biological tissues consistent with its intended use. Laboratory test results demonstrate that the material chosen and the design utilized in manufacturing Bard Soft Mesh will meet the established specifications necessary for consistent performance during its intended use. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol featuring three horizontal lines that curve and flow together, resembling a stylized human form. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR = 1 2004 Ms. Suzanne LaScalza Regulatory Affairs Associate Davol, Inc. 100 Sockanossett Crossroad Cranston, Rhode Island 02920 Re: K033814 Trade/Device Name: Bard Soft Mesh Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh polymeric Regulatory Class: II Product Code: FTL Dated: December 5, 2003 Received: December 9, 2003 Dear Ms. LaScalza: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Ms. Suzanne LaScalza This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Miriam C. Provost Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Indications for Use K033814 510(k) Number (if known): Device Name: Bard Soft Mesh Indications for Use: Indicated to reinforce soft tissue where weakness exists, i.e., repair of hernias and chest wall defects. X Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BLEOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Muriam C. Provost (Division Sign-Off) Division of General, I storative and Neurological Deves K033814 510(k) Number_ Page 1 of 1
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%